SCHEMBL23626691

SCHEMBL23626691

c1cc2ccc3cc(-c4ccc5oc6cc(-n7c8ccccc8c8cccnc87)ccc6c5c4)cc4ccc(c1)c2c34

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ NCOA1 Q15788 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23626697 0.88 MAPT (0.36) NPC1MAPTNCOA1ALDH1A1TSHR
SCHEMBL23626815 0.86 ALDH1A1 (0.34) GRM4NPC1MAPTNCOA1ALDH1A1
SCHEMBL26082011 0.85 ALDH1A1 (0.31) ALDH1A1TSHRCYP2C19
SCHEMBL26082258 0.85 ALDH1A1 (0.34) NPC1MAPTNCOA1ALDH1A1TSHR
SCHEMBL23626745 0.84 MAPT (0.35) GRM4NPC1MAPTNCOA1ALDH1A1
SCHEMBL23626700 0.84 KDM4E (0.38) NPC1MAPTNCOA1ALDH1A1TSHR
SCHEMBL23626814 0.84 ALDH1A1 (0.37) NPC1MAPTNCOA1ALDH1A1TSHR
SCHEMBL2628376 0.84 NPC1 (0.39) GRM4NPC1MAPTNCOA1ALDH1A1
SCHEMBL804873 0.83 MAPT (0.40) GRM4NPC1MAPTNCOA1ALDH1A1
SCHEMBL26082007 0.83 ALDH1A1 (0.33) NPC1MAPTNCOA1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-16 — — US disclosed
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-16 — — US disclosed
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 — — US disclosed
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 — — US disclosed
WO-2021136277-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2021-07-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE ODC1, LEF1, PIEZO1 GRM4 3265/4885NPC1 2724/4885MAPT 3152/4885
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device ODC1, LEF1, PIEZO1 GRM4 3265/4885NPC1 2724/4885MAPT 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback